TOR on the brain

Area of Science:

• Neuroscience
• Gerontology
• Molecular Biology

Background:

• Target of rapamycin (mTOR) signaling regulates fundamental cellular processes and lifespan across diverse organisms.
• In mice, chronic rapamycin treatment, which inhibits mTOR, extends lifespan.
• This suggests potential therapeutic applications of mTOR inhibition in aging and neurodegenerative diseases.

Purpose of the Study:

• To review the role of mTOR signaling in neuronal function, including feeding, synaptic plasticity, and memory.
• To explore the mechanisms by which reduced mTOR activity may benefit the aging brain.
• To examine the implications of mTOR signaling in Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Main Methods:

• Literature review of studies on mTOR signaling in model organisms and mammalian brains.
• Analysis of research investigating mTOR's role in neuronal regulation and brain function.
• Synthesis of findings from studies examining mTOR in age-related neurodegenerative conditions.

Main Results:

• mTOR signaling is crucial for neuronal functions such as feeding, synaptic plasticity, and memory formation.
• Reduced mTOR activity shows promise for extending lifespan and improving brain health in aging.
• Emerging evidence links dysregulated mTOR signaling to Alzheimer's, Parkinson's, and Huntington's diseases.

Conclusions:

• Modulating mTOR signaling represents a potential therapeutic strategy for age-related cognitive decline and neurodegenerative disorders.
• Further research into mTOR pathways is warranted to develop effective treatments for brain aging and diseases.
• Targeting mTOR may offer a novel approach to enhance brain resilience and combat neurodegeneration.